Akeso, Inc. (HKG:9926)
Hong Kong · Delayed Price · Currency is HKD 108.70
+2.40 (2.26%)
Sep 30, 2026, 4:08 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 100.13 billion as of October 1, 2026. Its market cap has decreased by -19.42% in one year.
Market Cap
100.13B
Enterprise Value
95.16B
Revenue
3.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
108.70
ChartMarket Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 100.13B, an increase of 439.95%. That is a compound annual growth rate of 29.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 100.13B | -3.81% |
| Dec 31, 2025 | 104.09B | 91.05% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 230.01B |
| Innovent Biologics | 170.70B |
| Sichuan Kelun-Biotech Biopharmaceutical | 116.40B |
| Genscript Biotech | 102.30B |
| Sino Biopharmaceutical | 101.69B |
| RemeGen | 64.58B |
| Biocytogen Pharmaceuticals (Beijing) | 57.60B |
| 3SBio | 41.30B |